We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Improved Prediction of Prostate Cancer Recurrence through Systems Pathology

Aureon Laboratories and their collaborators publish their 'Systems Pathology' model for predicting prostate cancer PSA recurrence in the Journal of Clinical Investigation.
News

Personalized Medicine: Milestone in the Therapy Control of Humanized Antibodies

CENiMED, BioTeZ and Invitek announce their cooperation to develop, produce and market the Recovery-ELISAs for the therapy control of humanized antibodies.
News

Abbott Announces Termination of Contract with GE

Abbott and GE have mutually agreed to terminate their contract for the sale of Abbott’s core laboratory and point-of-care diagnostics businesses to GE.
News

EMBL Expands to Australia

Delegates representing the 19 member states of the EMBL offered Australia associate membership in EMBL’s international community.
News

Canadian Scientists Identify Chromosome Linked to Colorectal Cancer

Researchers at the Ontario Institute for Cancer Research have identified a genetic variation on chromosome 8 associated with colorectal cancer.
News

Roche Completes Acquisition of BioVeris

Roche Diagnostics now owns the patents for Electrochemiluminescence technology and can expand its immunochemistry into new market segments.
News

Substance in Tree Bark Could Lead to new Lung-Cancer Treatment

UT Southwestern researchers determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells.
News

Weill Cornell Medical College Team Identifies Potential new Cancer Drug Target

Weill Cornell researchers have uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP.
News

Abraxis BioScience Signs Licensing Agreement with University of Southern California

Abraxis exclusively licenses property portfolio designed to personalize treatment for colorectal cancer from the University of Southern California.
News

Study Suggests Breast Cancer Drug may Protect Heart

Duke researchers have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
Advertisement